Drugs / Inhaled FF 200mcg/GW642444M 25mcg
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01266941 | Oct 2010 → Jul 2011 | asthma | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inhaled FF 200mcg/GW642444M 25mcg | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01266941 ↗ |
| Route | Inhaled | “inhaled FF 200mcg/GW642444M 25mcg” NCT01266941 ↗ |